Pharmafile Logo
Pharmafocus logo
Advanced Search

Johnson & Johnson

Showing 15 posts of 137 posts found.

36745826313_86e4ffa6ac_b

New Johnson & Johnson study aiming to add stroke detection to Apple Watch

February 26, 2020
Research and Development Apple, Janssen, Johnson & Johnson, apple watch, iphone, stroke

Johnson & Johnson announced that Janssen Pharmaceuticals will work in collaboration with Apple to explore apps for stroke detection. It …

News
26795063175_fe37f336f7_b

Jury orders Johnson & Johnson to pay $750 million in latest baby powder case

February 7, 2020
Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder

Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …

News

Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial

January 28, 2020
Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder

Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …

News
26419186961_6507de1a5d_b

US judge slashes Johnson & Johnson damages in Risperdal case

January 20, 2020
Sales and Marketing Big Pharma, Johnson & Johnson, Johnson & Johnson talc powder

A judge in Philadelphia has reduced the amount of damages Johnson & Johnson was ordered to pay by a jury …

News
26795071995_1a72be4ca3_b

No link between talc and ovarian cancer, new study reveals

January 8, 2020
Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder

Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …

News
19916066779_1a281ebca0_b

Johnson & Johnson sued by Washington State for role in the opioid crisis

January 3, 2020
Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids

The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …

News
jj

J&J’s CAR-T candidate boasts 100% response rate in relapsed or refractory multiple myeloma

December 9, 2019
Research and Development, Sales and Marketing ASH 2019, CAR-T, J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson were present at the American Society of Hematology (ASH) Annual Meeting over the weekend to unveil new …

News
johnson_and_johnson_jj_4

J&J to supply 500,000 Ebola vaccines to fight DR Congo outbreak

November 7, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Ebola, Janssen, Johnson & Johnson, pharma

Johnson & Johnson has reached an agreement with the Government of the Democratic Republic of the Congo (DRC) to supply …

News

J&J must pay $572 million for fuelling opioid crisis in Oklahoma, judge says

August 27, 2019
Manufacturing and Production J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, opioids, pharma

A judge in Oklahoma has said that Johnson & Johnson must pay $572 million for the part it played in …

News

J&J’s ponesimod meets primary and secondary endpoints at Phase 3 in relapsing multiple sclerosis

July 26, 2019
Medical Communications, Research and Development Johnson & Johnson, multiple sclerosis, pharma, ponesimod

New Phase 3 data has been released on Johnson & Johnson’s selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod, reporting that …

News

J&J ‘worse’ than Purdue Pharma expert witness says

June 12, 2019
Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra

The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …

News

J&J pay $9.9 million to settle surgical mesh implant case

April 23, 2019
Manufacturing and Production . Johnson & Johnson, J&J, JJ, Johnson & Johnson, Litigation, washington

Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s …

News
janssen_latest_logo_on_sign

Janssen closes plant in California, 49 positions axed

April 3, 2019
Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, Vacaville, california

Janssen are letting go of 49 employees due to the closure of their plant in Vacaville, California. The Johnson & …

News

Indian authorities say J&J’s baby shampoo contains ‘harmful ingredients’

April 1, 2019
Sales and Marketing Cancer, India, J&J, JJ, Johnson & Johnson, Rajasthan, baby shampoo, formaldehyde

Indian authorities in the state of Rajasthan have said that samples taken from Johnson & Johnson’s baby shampoo contained ‘harmful …

News
mouse

J&J bows to PETA pressure and drops forced swim tests in mice

March 21, 2019
Medical Communications J&J, JJ, Johnson & Johnson, PETA, animal welfare, pharma

Johnson & Johnson has announced it is to end its practice of forced swim tests on mice, rats and other …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024